- Result of Beijing’s price controls: Chinese patients are getting inferior drugs. (NYT)
- A group of people in Chicago were asked whether a hypothetical 2-year-old named J.L. who has not been vaccinated against measles, mumps or rubella will get sick and require hospitalization. Their initial estimate of harm dropped about 20 percent after they were informed that “there are thousands of children who are J.L.’s age in Chicago who have not been vaccinated against measles, mumps or rubella.”
- The case against RFK, Jr.
- DeepSeek fails Econ 101.
- More thoughts on DeepSeek.
Category: Drug Prices & Regulations
Is Aging a Disease? Why It Matters
I’m not getting any younger, as they say. That’s a cliché but is it a disease? Some scientists believe so and would like the U.S. Food and Drug Administration (FDA) to classify aging as exactly that, not a function of our calendar that inevitably leads to diseases of old age, but a disease itself.
Tuesday Links – 28 January 2025
- Disruptive innovation in health care.
- In response to the payment change, annual incident dementia diagnosis rates in Medicare Advantage increased by 11.5 percent relative to traditional Medicare.
- Why government administered pricing of drugs isn’t working.
- What gerrymandering produces: Just 8 percent of congressional races and 7 percent of state legislative races were decided by fewer than five percentage points. (NYT)
Monday Links
- “A close look at the data indicates that loneliness may not be any worse now than it has been for much of history.”
- The case against tariffs.
- Why we need HSAs for gig workers.
- 48.5 million Americans have a substance abuse disorder involving alcohol or drugs or both.
- We could have had Ozempic 40 years ago. (NYT)